Aix Marseille Université-CNRS, Laboratoire de Neurosciences Cognitives, LNC UMR 7291, Marseille, Groupe de Recherche Vertige (GDR#2074), France.
Normandie Université, UNICAEN, INSERM, COMETE, CYCERON, CHU Caen, 14000, Caen, France.
Curr Neuropharmacol. 2024;22(11):1826-1845. doi: 10.2174/1570159X22666240319123151.
Most neurotransmitter systems are represented in the central and peripheral vestibular system and are thereby involved both in normal vestibular signal processing and the pathophysiology of vestibular disorders. However, there is a special relationship between the vestibular system and the histaminergic system. The purpose of this review is to document how the histaminergic system interferes with normal and pathological vestibular function. In particular, we will discuss neurobiological mechanisms such as neuroinflammation that involve histamine to modulate and allow restoration of balance function in the situation of a vestibular insult. These adaptive mechanisms represent targets of histaminergic pharmacological compounds capable of restoring vestibular function in pathological situations. The clinical use of drugs targeting the histaminergic system in various vestibular disorders is critically discussed.
大多数神经递质系统都存在于中枢和外周前庭系统中,因此既参与正常的前庭信号处理,也参与前庭疾病的病理生理学过程。然而,前庭系统与组胺能系统之间存在特殊关系。本文综述的目的是记录组胺能系统如何干扰正常和病理性前庭功能。特别是,我们将讨论涉及组胺的神经生物学机制,如神经炎症,以调节和允许在前庭损伤的情况下恢复平衡功能。这些适应性机制是组胺能药物化合物的作用靶点,这些化合物能够在病理情况下恢复前庭功能。本文还批判性地讨论了在各种前庭疾病中靶向组胺能系统的药物的临床应用。